These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 9005744)

  • 1. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.
    Doney K; Leisenring W; Storb R; Appelbaum FR
    Ann Intern Med; 1997 Jan; 126(2):107-15. PubMed ID: 9005744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy.
    Yoshida N; Kobayashi R; Yabe H; Kosaka Y; Yagasaki H; Watanabe K; Kudo K; Morimoto A; Ohga S; Muramatsu H; Takahashi Y; Kato K; Suzuki R; Ohara A; Kojima S
    Haematologica; 2014 Dec; 99(12):1784-91. PubMed ID: 25193958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia.
    Hinterberger W; Rowlings PA; Hinterberger-Fischer M; Gibson J; Jacobsen N; Klein JP; Kolb HJ; Stevens DA; Horowitz MM; Gale RP
    Ann Intern Med; 1997 Jan; 126(2):116-22. PubMed ID: 9005745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia.
    Arai Y; Kondo T; Yamazaki H; Takenaka K; Sugita J; Kobayashi T; Ozawa Y; Uchida N; Iwato K; Kobayashi N; Takahashi Y; Ishiyama K; Fukuda T; Ichinohe T; Atsuta Y; Mori T; Teshima T;
    Haematologica; 2016 May; 101(5):644-52. PubMed ID: 26858357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
    Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.
    Gadalla SM; Wang T; Haagenson M; Spellman SR; Lee SJ; Williams KM; Wong JY; De Vivo I; Savage SA
    JAMA; 2015 Feb; 313(6):594-602. PubMed ID: 25668263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marrow transplant experience for children with severe aplastic anemia.
    Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Allogenic hematopoietic stem cell transplantation in acquired aplastic anemia: first experience of the National Center for Bone Marrow Grafting].
    Abdelkefi A; Ladeb S; Ben Othman T; Torjman L; Jeddi R; Ben Abdeladhim A
    Tunis Med; 2001 Oct; 79(10):498-502. PubMed ID: 11910688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival in severe acquired aplastic anemia of childhood.
    Fouladi M; Herman R; Rolland-Grinton M; Jones-Wallace D; Blanchette V; Calderwood S; Doyle J; Halperin D; Leaker M; Saunders EF; Zipursky A; Freedman MH
    Bone Marrow Transplant; 2000 Dec; 26(11):1149-56. PubMed ID: 11149724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy.
    Deeg HJ; Seidel K; Casper J; Anasetti C; Davies S; Gajeweski JL; Territo M; Ramsay N; Harris RE; Catro-Malaspina H; Collins R; Champlin R; Schoch G; King R; Howe C
    Biol Blood Marrow Transplant; 1999; 5(4):243-52. PubMed ID: 10465104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).
    Locasciulli A; Oneto R; Bacigalupo A; Socié G; Korthof E; Bekassy A; Schrezenmeier H; Passweg J; Führer M;
    Haematologica; 2007 Jan; 92(1):11-8. PubMed ID: 17229630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia.
    Yoshimi A; Strahm B; Baumann I; Furlan I; Schwarz S; Teigler-Schlegel A; Walther JU; Schlegelberger B; Göhring G; Nöllke P; Führer M; Niemeyer CM
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):425-9. PubMed ID: 24316460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.
    Socié G; Henry-Amar M; Bacigalupo A; Hows J; Tichelli A; Ljungman P; McCann SR; Frickhofen N; Van't Veer-Korthof E; Gluckman E
    N Engl J Med; 1993 Oct; 329(16):1152-7. PubMed ID: 8377778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anemia.
    Castro-Malaspina H; Childs B; Laver J; Shank B; Brochstein J; Gillio A; Flomenberg N; Young J; Boulad F; Black P
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):847-54. PubMed ID: 8040033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.
    Bacigalupo A; Socié G; Schrezenmeier H; Tichelli A; Locasciulli A; Fuehrer M; Risitano AM; Dufour C; Passweg JR; Oneto R; Aljurf M; Flynn C; Mialou V; Hamladji RM; Marsh JC;
    Haematologica; 2012 Aug; 97(8):1142-8. PubMed ID: 22315497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
    van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM
    Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial.
    Ahn MJ; Choi JH; Lee YY; Choi IY; Kim IS; Yoon SS; Park SY; Kim BK; Suh C; Son HJ; Jung CW; Lee JH; Sung JM; Im SA; Oh D; Jung SY; Yoon HJ; Cho KS; Lee JA; Yuh YJ; Kim SR; Ki M
    Int J Hematol; 2003 Aug; 78(2):133-8. PubMed ID: 12953807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
    Maury S; Balère-Appert ML; Chir Z; Boiron JM; Galambrun C; Yakouben K; Bordigoni P; Marie-Cardine A; Milpied N; Kanold J; Maillard N; Socié G;
    Haematologica; 2007 May; 92(5):589-96. PubMed ID: 17488681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial.
    DeZern AE; Eapen M; Wu J; Talano JA; Solh M; Dávila Saldaña BJ; Karanes C; Horwitz ME; Mallhi K; Arai S; Farhadfar N; Hexner E; Westervelt P; Antin JH; Deeg HJ; Leifer E; Brodsky RA; Logan BR; Horowitz MM; Jones RJ; Pulsipher MA
    Lancet Haematol; 2022 Sep; 9(9):e660-e669. PubMed ID: 35907408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.